United States · FDA National Drug Code directory
LAMIVUDINE and ZIDOVUDINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-900_415d1735-9f33-0e91-e063-6394a90a16de
- Product NDC
- 43063-900
- Form
- TABLET, FILM COATED
- Composition / generic term
- LAMIVUDINE and ZIDOVUDINE
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150918
- Source listing expiry
- 20261231
Source-listed ingredients
- LAMIVUDINE — 150 mg/1
- ZIDOVUDINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-900-06) · 43063-900-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →